Pasithea Therapeutics Reports Encouraging Safety and Preliminary Efficacy in Phase 1 Cancer Trial of PAS-004
Sep 26, 2024
Oncology Stock Market Invest
Pyxis Oncology Discloses Inducement Grants According to Nasdaq Rule
Jun 29, 2024
SOPHiA GENETICS Unveils Groundbreaking RAM Application in Fight Against Acute Myeloid Leukemia
Jun 24, 2024
ADC Therapeutics Awards Stock Options to New Employees as Part of Inducement Plan
Jun 4, 2024
Corbus Pharmaceuticals Reports Promising Results for SYS6002 in Nectin-4 Positive Tumor Treatment
Jun 2, 2024
CG Oncology Reports Positive Data for Cretostimogene in Concert with Pembrolizumab at ASCO 2024
Apr 24, 2024
Pyxis Oncology Scheduled to Take the Stage at the Upcoming Leerink Global Biopharma Conference in 2024
Mar 8, 2024
Cellectar Biosciences Announces Promising Results for Iopofosine in Head and Neck Cancer Treatment
Mar 5, 2024
The International Myeloma Foundation Announces the Loss of Esteemed Board Member Dr. Edith Mitchell
Jan 24, 2024
The International Myeloma Foundation Honors the Legacy of Dr. Edith Mitchell
Jan 23, 2024
Cellectar Biosciences Achieves Milestone in CNS Lymphoma with Iopofosine I 131
Jan 22, 2024
Pyxis Oncology Announces New Inducement Grants in Compliance with Nasdaq Rules
Dec 30, 2023
FDA Completes Review of Amgen's Supplemental Application for LUMAKRAS® (sotorasib)
Dec 27, 2023
C4 Therapeutics (CCCC) Jumps on Innovative Cancer Deal with Merck
Dec 13, 2023
Arvinas and Pfizer Reveal Advanced Vepdegestrant Data at 2023 SABCS
Nov 29, 2023
Kineta, Inc. to Present New Clinical Data at Upcoming KOL Event
Nov 28, 2023
Immix Biopharma Receives FDA Nod for CAR-T Cell Therapy IND, Eyes U.S. Treatment Commencement
Nov 21, 2023
Novartis to Unveil Key Data from Breast Cancer and Hematology Studies at SABCS and ASH Meetings
Nov 20, 2023
Molecular Partners AG to Showcase DARPin Therapeutic Advances at PEGS Europe Summit
Nov 14, 2023
Moleculin Biotech Announces Q3 2023 Financials with Strong Cash Position and Promising Clinical Data
Nov 14, 2023
Achilles Therapeutics Announces Q3 2023 Financials and Progress in Patient Dosing
Nov 14, 2023